Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
about
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveThe inflammatory protein Pentraxin 3 in cardiovascular diseaseThe Dual Complexity of PTX3 in Health and Disease: A Balancing Act?Inflammatory Long Pentraxin 3 is Associated with Leukocyte Telomere Length in Night-Shift Workers.Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of AtherosclerosisHELP LDL apheresis reduces plasma pentraxin 3 in familial hypercholesterolemia.Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilationRutaecarpine suppresses atherosclerosis in ApoE-/- mice through upregulating ABCA1 and SR-BI within RCT.Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul StudyPentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY Studies.Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3.Blood monocyte chemotactic protein-1 (MCP-1) and adapted disease activity Score28-MCP-1: favorable indicators for rheumatoid arthritis activity.Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.A RTK-based functional RNAi screen reveals determinants of PTX-3 expression.Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.Consolidated and emerging inflammatory markers in coronary artery diseaseIncremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.Associations between pentraxin 3 and severity of coronary artery disease.Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosisInverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal diseaseAn acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair modePentraxin 3: a novel biomarker for inflammatory cardiovascular diseaseCorrelation between pentraxin-3 and endothelial dysfunction in obstructive sleep apnea syndrome.Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory responsemiR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.PTX3 controls activation of matrix metalloproteinase 1 and apoptosis in conjunctivochalasis fibroblasts.Biochemical analysis of pentraxin 3 and fibrinogen levels in experimental periodontitis model.Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases.Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal ModelsEffect of flaxseed supplementation and exercise training on lipid profile, oxidative stress and inflammation in rats with myocardial ischemia.Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps.The "sweet" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation.Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up studyRelationship between Plasma Pentraxin-3, Neutrophil-to-Lymphocyte Ratio, and Atherosclerosis in Renal Transplant Patients.
P2860
Q24594814-403D5780-CE33-49F3-A65F-31CEAE715E55Q26738957-3E9432C0-064F-4096-9C36-488650D1C5BEQ33632047-0A73E4E2-C994-4E3E-ADB7-BE6C86A11110Q33650222-95E5C31C-E212-4931-8D42-AEE185EA10A1Q33748025-FF6D87F0-E412-4582-9AF1-071A7F9903F0Q33889411-8A816C88-990A-41EF-9A0C-D7C49D409650Q33944773-07F6B1B4-EB02-4633-AE62-38ED702C61FCQ33945072-B3925256-E718-4F97-B85D-341501F04EE3Q34150807-1A9AAFF4-0695-453D-B5B7-23104C45F2B7Q34154838-76A153E6-A9CF-4F24-BFAD-0A4534E6F305Q34534979-B2F65C89-5970-4A58-9BC4-45102C09C70CQ34543068-E424301D-9339-4C5F-B691-CD64A6EF25EBQ34576441-F9313F17-3BF9-4654-A1F5-620A24B51897Q34579101-17B76C0F-64CC-4A1B-993D-828FA3ECD1CCQ34662196-EE8E3636-D68D-4980-AABC-6491691154D3Q34713240-3604018B-8054-42FA-92B6-B77D3D086026Q34751855-53CB2605-3B20-4000-A555-341BEEC8FBF0Q35019922-5C69A6F6-CEE9-4DA1-B827-9AD24D1A563EQ35026270-2AA76A3C-CC67-43BC-AB65-448DA4F87274Q35133148-ACDAEE50-55C5-4AC9-8282-EB44DF0C4719Q35140370-DD035A8D-917F-4C20-9268-79741BE89C90Q35332533-190C213D-1E00-41A4-B989-457A6DFE760DQ35556624-A55FFCF4-B6D8-4792-97C1-EEE39C0F3585Q35664554-97B58F57-CC39-4889-97B4-338BB2161C0BQ35671242-1D6294AE-6262-4223-8494-8878EE8A19DBQ35755280-115EC3D8-883F-43CD-B741-6C7D70927614Q35898602-E4D7C5C3-D8B8-4551-BC9A-EDDD4ACEC778Q35915482-AE967AB0-1C9D-42C3-921B-F184FC70840EQ35970092-E2248AC1-6785-41F7-A918-69356BC2AFD8Q36076997-E6FC4B32-90A1-4DDD-95A2-8DA1D7BE7402Q36200128-0E571FFE-6DD3-4E05-B998-F1A5EB38E3CEQ36287340-2CAB3860-B4EA-43AA-8BEC-2D99E94A9AB3Q36330303-BCF8B41A-743D-457C-8323-5E7BB9D5AD1CQ36366126-32FEEF0E-9395-4C03-A387-A7F9FDA65630Q36430516-AD32033C-FE7E-4B83-AB59-B5D93E1F3DF3Q36463833-45FD3FF5-CADE-46DA-8364-E8141A93B7D5Q36516810-4F4EF9EF-D70A-4D0F-8F19-ED32E736CAA6Q36533057-A1A09419-9F96-4221-A1AE-BF0E11B98DC6Q36538797-0487F9BC-7A92-4BF2-86CC-7F42847EC3AFQ36551416-B53E87FD-F1C2-48AA-92B2-0D19554A4152
P2860
Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
description
im August 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2009
@uk
name
Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
@en
Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
@nl
type
label
Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
@en
Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
@nl
prefLabel
Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
@en
Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
@nl
P2093
P50
P1433
P1476
Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
@en
P2093
Fabio Pasqualini
Irene Pizzitola
Patrizia Marchesi
P304
P356
10.1161/CIRCULATIONAHA.108.806547
P407
P50
P577
2009-08-25T00:00:00Z